“DIFFERENCES IN EX-VIVO CHEMOSENSITIVITY TO ANTHRACYCLINES IN FIRST LINE ACUTE MYELOID LEUKEMIA”, Mediterr J Hematol Infect Dis, vol. 11, no. 1, p. e2019016, Feb. 2019, doi: 10.4084/mjhid.2019.016.